Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma
Clinical trial NCT00705874 · COMPLETED
Trial details
- NCT number
- NCT00705874
- Sponsor
- Progen Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2011-08-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.